BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 7612235)

  • 1. The three-dimensional structure of peptide-MHC complexes.
    Madden DR
    Annu Rev Immunol; 1995; 13():587-622. PubMed ID: 7612235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between immunogenic peptides and MHC proteins.
    Rothbard JB; Gefter ML
    Annu Rev Immunol; 1991; 9():527-65. PubMed ID: 1910688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
    Persson K; Schneider G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
    Hill CM; Hayball JD; Allison AA; Rothbard JB
    J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular components of T-cell recognition.
    Jorgensen JL; Reay PA; Ehrich EW; Davis MM
    Annu Rev Immunol; 1992; 10():835-73. PubMed ID: 1591005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting peptide binding to Major Histocompatibility Complex molecules.
    Liao WW; Arthur JW
    Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ternary complex: T cell receptor, MHC protein, and immunogenic peptide.
    Rothbard JB
    Semin Immunol; 1990 Sep; 2(5):283-95. PubMed ID: 2134014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to a class II major histocompatibility complex molecule.
    Driscoll PC; Altman JD; Boniface JJ; Sakaguchi K; Reay PA; Omichinski JG; Appella E; Davis MM
    J Mol Biol; 1993 Jul; 232(2):342-50. PubMed ID: 8393933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
    Wu S; Gorski J; Eckels DD; Newton-Nash DK
    J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting interactions between T cell receptors and MHC-peptide complexes.
    Roomp K; Domingues FS
    Mol Immunol; 2011 Jan; 48(4):553-62. PubMed ID: 21106246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
    Zhang C; Anderson A; DeLisi C
    J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.